Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.267.00 CHF
Change Today +10.00 / 3.89%
Volume 1.6M
ROG On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
As of 11:43 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for roche holding ag-genusschein (ROG)

Although debt as a percent of total capital increased at Roche Holding AG over the last fiscal year to 54.43%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 64.01 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 192.86 days.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
CHF
Dec 31
2012
Restated
CHF
Dec 31
2013
Reclassified
CHF
Dec 31
2014
CHF
4 Year
Trend
Assets    
Cash and Equivalents3,998.04,699.24,149.43,881.8
Short-Term Investments7,710.79,814.58,231.58,258.4
Trading Asset Securities9.35.22.119.7
TOTAL CASH AND SHORT TERM INVESTMENTS11,718.014,518.912,383.012,159.9
Accounts Receivable9,976.39,632.98,945.29,199.3
Notes Receivable157.7146.3146.397.5
Other Receivables1,370.41,417.01,360.01,911.9
TOTAL RECEIVABLES11,504.311,196.210,451.411,208.7
Inventory5,249.05,749.06,126.68,032.3
Prepaid Expenses397.3436.7435.7489.6
Restricted Cash------4.1
Other Current Assets418.1642.1856.9381.7
TOTAL CURRENT ASSETS29,286.732,543.030,253.632,276.4
Gross Property Plant and Equipment32,222.532,418.532,623.935,619.8
Accumulated Depreciation-15,416.2-16,441.1-16,275.1-17,782.4
NET PROPERTY PLANT AND EQUIPMENT16,806.315,977.416,348.817,837.4
Goodwill8,136.07,759.57,411.910,320.7
Long-Term Investments317.4213.7229.3255.2
Accounts Receivable, Long Term36.321.812.418.7
Loans Receivable, Long Term6.212.412.411.4
Deferred Tax Assets, Long Term2,865.25,030.24,882.92,934.7
Other Intangibles5,317.54,371.44,091.313,362.2
Other Long-Term Assets1,104.81,299.81,246.91,450.2
TOTAL ASSETS63,876.567,229.264,489.678,466.9
    
LIABILITIES & EQUITY    
Accounts Payable1,258.31,669.11,846.52,482.4
Accrued Expenses7,095.57,654.77,669.28,965.9
Short-Term Borrowings1,060.2336.1728.23,437.8
Current Portion of Long-Term Debt/Capital Lease2,460.66,645.31,635.93,202.3
Current Portion of Capital Lease Obligations17.619.720.725.9
Current Income Taxes Payable2,288.42,292.61,872.42,713.7
Other Current Liabilities, Total2,265.62,204.42,250.02,963.7
Unearned Revenue, Current386.9161.8346.5205.4
TOTAL CURRENT LIABILITIES16,815.620,964.016,348.823,971.3
Long-Term Debt24,119.718,336.416,872.719,912.1
Capital Leases215.8190.9163.9157.7
Minority Interest2,476.22,319.52,019.72,045.7
Unearned Revenue, Non-Current65.4102.7106.899.6
Pension & Other Post-Retirement Benefits5,726.27,501.26,288.59,330.0
Deferred Tax Liability Non-Current626.61,449.21,329.9627.6
Other Non-Current Liabilities1,284.31,309.11,344.42,005.2
TOTAL LIABILITIES48,853.449,853.442,455.056,103.5
Common Stock166.0166.0166.0166.0
Retained Earnings17,910.020,789.726,601.027,129.0
Comprehensive Income and Other-5,529.1-5,899.5-6,752.2-6,977.3
TOTAL COMMON EQUITY12,546.915,056.220,014.820,317.7
TOTAL EQUITY15,023.017,375.822,034.622,363.4
TOTAL LIABILITIES AND EQUITY63,876.567,229.264,489.678,466.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.267.00 CHF +10.00

ROG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergan plc $312.00 USD +6.02
Amgen Inc $155.72 USD +1.74
General Electric Co $25.01 USD +1.00
Gilead Sciences Inc $107.99 USD +1.03
Johnson & Johnson $96.22 USD +1.11
View Industry Companies
 

Industry Analysis

ROG

Industry Average

Valuation ROG Industry Range
Price/Earnings 24.6x
Price/Sales 4.3x
Price/Book 12.7x
Price/Cash Flow 20.1x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.